XRCC4 and ovarian carcinoma: To glean a comprehensive mechanistic insight into how XRCC4 is upregulated to promote cisplatin-resistant in ovarian cancer cells, we first used the PROMO database to predict the transcription factors (TFs) that may mediate the transcription of XRCC4.